Covered recipient · General Payments record
BRANDON JOSEPH CROUCH
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$508.18
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $402.55 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $164.15 | 13 |
| Acerta Pharma LLC | $92.47 | 5 |
| Novo Nordisk AS | $32.75 | 2 |
| Edwards Lifesciences Corporation | $27.70 | 1 |
| Astellas Pharma US Inc | $23.94 | 1 |
| GlaxoSmithKline, LLC. | $17.95 | 1 |
| PFIZER INC. | $16.07 | 1 |
| Lilly USA, LLC | $14.12 | 1 |
| Amgen Inc. | $13.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202020212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.11 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517516 | CMS |
| ABBVIE INC. | $15.30 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517518 | CMS |
| ABBVIE INC. | $13.04 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517520 | CMS |
| ABBVIE INC. | $16.19 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517522 | CMS |
| ABBVIE INC. | $17.71 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517524 | CMS |
| ABBVIE INC. | $9.69 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517526 | CMS |
| ABBVIE INC. | $11.40 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517528 | CMS |
| ABBVIE INC. | $20.42 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517530 | CMS |
| ABBVIE INC. | $3.16 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517532 | CMS |
| ABBVIE INC. | $21.43 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517534 | CMS |
| ABBVIE INC. | $5.50 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517536 | CMS |
| ABBVIE INC. | $11.58 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517538 | CMS |
| ABBVIE INC. | $4.62 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103517540 | CMS |
| Amgen Inc. | $13.40 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117231247 | CMS |
| Astellas Pharma US Inc | $23.94 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139275358 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.26 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104748523 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.66 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105853910 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.14 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104201643 | CMS |
| AstraZeneca Pharmaceuticals LP | $26.26 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104303972 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.15 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105844699 | CMS |
| Edwards Lifesciences Corporation | $27.70 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138855454 | CMS |
| GlaxoSmithKline, LLC. | $17.95 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116689539 | CMS |
| Lilly USA, LLC | $14.12 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136073041 | CMS |
| Novo Nordisk Inc | $16.50 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097405806 | CMS |
| Novo Nordisk Inc | $16.25 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096640369 | CMS |
| PFIZER INC. | $16.07 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131272352 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.